Anthropic, a smaller rival started by OpenAI defectors, has found runaway success with its programming agent, Claude Code.
Malware is evolving to evade sandboxes by pretending to be a real human behind the keyboard. The Picus Red Report 2026 shows 80% of top attacker techniques now focus on evasion and persistence, ...
Meta is rolling out a dedicated shopping research mode inside its Meta AI web chatbot for a slice of US desktop users. Search ...
The 75,000-plus families that have signed up for New York City’s free 3-K and pre-K programs are still thousands short of last year’s final count with only two days to go until the deadline, the Daily ...
When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...
BP has suspended its share buyback program and increased its cost-cutting goal by $1.5 billion to bolster its balance sheet and increase investment in oil production. The company's current struggles ...
For Windows users, Task Manager is an indispensable tool—but it's also a flawed one for those trying to troubleshoot their PC when it slows down, and AppControl looks to improve those scenarios ...
Update, February 13, 2026 (02:31 PM ET): We’re a couple days behind schedule now, but Google has finally confirmed the arrival of Android 17 Beta 1. Update, February 11, 2026 (02:21 PM ET): While ...
Trump admin issues major new rule for truck drivers Descendant of enslaver uses eminent domain to target major Black-owned Georgia farm Nobel economist warns a dearth of blue-collar jobs is among the ...
Imagine a dedicated coach training a talented athlete. One day, the athlete’s performance inexplicably drops. They’re slower, their form is off, and they struggle with drills they mastered weeks ago.
Current school board member Rae Gallagher said she hopes to continue preserving protections and programs for students in her reelection run for the Frederick County Board of Education. She said she ...
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.